07 April 2021 1 Min Read
Biotech start-up Vaccitech files for US IPO
Vaccitech owns the technology behind the Covid-19 vaccine developed by Oxford and AstraZeneca
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In